A Stem Cell Biotechnology Company

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells.

OTCQB: BRTX
0.00
+0.00
(+0.00%)

Our two core programs, as described below, relate to the treatment of disc/spine disease and metabolic disorders:

brtxDISC™

Disc/Spine Program

Our lead cell therapy candidate, brtxDISC™ (Disc Implanted Stem Cells), is a product formulated from autologous (or a person’s own) cultured mesenchymal stem cells collected from the patient’s bone marrow.

Learn More

ThermoStem®

Metabolic Program

We are developing an allogeneic cell-based therapy to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (“BAT”).

Learn More

Company Information

Vestibulum rutrum quam vitae fringilla tincidunt. Suspendisse nec tortor urna. Ut laoreet sodales nisi, quis iaculis.

Stock Information

Keytar McSweeney's Williamsburg, readymade leggings try-hard 90's street art letterpress hoodie occup.

Events and Presentations

Nam porttitor blandit accumsan. Ut vel dictum sem, a pretium dui. In malesuada enim in dolor euismod.

Investor FAQ

Mauris non tempor quam, et lacinia sapien. Mauris accumsan eros eget libero posuere vulputate. Etiam elit elit elem.

Corporate Governance

Nam porttitor blandit accumsan. Ut vel dictum sem, a pretium dui. In malesuada enim in dolor euismod.

Investor Contacts

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut pretium pretium tempor. Ut eget imperdie.